Etude thyrovir: Involvement of Viral Infections in the Pathogenesis of Chronic Lymphocytic Thyroiditis

Sponsor
Centre Hospitalier Universitaire, Amiens (Other)
Overall Status
Completed
CT.gov ID
NCT03114267
Collaborator
(none)
64
1
36
1.8

Study Details

Study Description

Brief Summary

Autoimmune diseases represent a heterogeneous group of pathologies whose etiopathogenic mechanisms are most often unknown. Autoimmune diseases are the leading cause of morbidity and mortality in young women and autoimmune thyroid diseases are the most common.

Viral infections are the main environmental factors suspected of triggering autoimmune diseases. Several viruses are certainly involved, all of which are possibly capable of triggering an autoimmune response. However, the precise identification of the viruses involved remains to be established.

It has been shown for the first time by the 2005 PHRC that enteroviral RNA is present in perioperative specimens of thyroid tissue. However, this case-control study did not show any difference between the thyroid group and the group other thyroid pathologies It has been recently published that Parvovirus is possibly involved in thyroiditis: the parvoviral genome is present in the thyroid tissue of Hashimoto thyroiditis operated and more precisely is present within the thyrocytes itself.

Condition or Disease Intervention/Treatment Phase
  • Other: Comparison of the prevalences of the parvovirus genome

Study Design

Study Type:
Observational
Actual Enrollment :
64 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Involvement of Viral Infections in the Pathogenesis of Chronic Lymphocytic Thyroiditis
Actual Study Start Date :
Jan 6, 2012
Actual Primary Completion Date :
Jan 6, 2015
Actual Study Completion Date :
Jan 6, 2015

Arms and Interventions

Arm Intervention/Treatment
Patient with chronic lymphocytic thyroiditis

Other: Comparison of the prevalences of the parvovirus genome
Comparison of the prevalences of the parvovirus genome between cases and controls and then of other viruses according to the results of parvoviruses and data from the literature

Healthy subjects

Other: Comparison of the prevalences of the parvovirus genome
Comparison of the prevalences of the parvovirus genome between cases and controls and then of other viruses according to the results of parvoviruses and data from the literature

Outcome Measures

Primary Outcome Measures

  1. Analysis of the viral genome by PCR carried out in the Virology department, Analysis of the presence of capsid protein [1 day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients participating in PHRC 2005 "involvement of enteroviruses in TLC pathogenesis"

  • Inclusion of TLC: presence of a significant lymphocyte infiltrate within the thyroid parenchyma defined by the presence of clusters of more than 30 to 50 lymphocytes

  • Inclusion of controls: absence of significant lymphocyte infiltrate

Exclusion Criteria:
  • Persons refusing to participate in research

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Amiens Picardie Amiens Picardie France 80054

Sponsors and Collaborators

  • Centre Hospitalier Universitaire, Amiens

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier:
NCT03114267
Other Study ID Numbers:
  • PI11-PR-DESAILLOUD-1
First Posted:
Apr 14, 2017
Last Update Posted:
Apr 14, 2017
Last Verified:
Apr 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 14, 2017